Sponsor: EMD Millipore
Data presented in this webinar illustrates the value of live cell analysis at the single-cell level to identify differences in expression levels across populations of cells. The cells remain intact for downstream analysis. Our experts also discuss the use of SmartFlare RNA detection probes for the direct quantification of circulating miRNAs with rapid processing of blood plasma/serum, which is done without the use of enzymes. Using circulating miRNAs with established roles in cancer and quality control, we can accurately detect these miRNAs in plasma using a microplate fluorometer within an hour after plasma preparation.
On-demand recording is available here.
In addition to a stifling
In addition to a stifling bureaucracy, big pharma has not been able to come up with a model to reward it scientists for high fail rates, which is the flip side of adopting innovative approaches. In this environment, scientists follow more conservative approaches for drug discovery; senior management criticizes the lack of internal creativity and looks to the biotech world to feed its pipeline. Of course big pharma will find that going with biotech alone is no panacea, as it has its own limitations.